ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1,2,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1,3,Anosmia,Olfactory nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
1,4,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
1,5,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
1,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1,8,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
1,9,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
1,10,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1,11,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1,12,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1,13,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1,14,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
2,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
2,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
2,3,Headache,Headaches NEC,Headaches,Nerv,N
2,4,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
3,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
3,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
4,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
5,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
6,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
7,1,Bell's palsy,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
8,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
9,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
10,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
12,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
13,1,Central venous catheterisation,Venous therapeutic procedures,Vascular therapeutic procedures,Surg,N
13,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
13,3,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
13,4,Varicella,Herpes viral infections,Viral infectious disorders,Infec,N
14,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
15,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
16,1,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
16,2,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
17,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
17,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
17,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
17,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
18,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
19,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
19,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,Y
19,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,4,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
19,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
20,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
20,2,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
21,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
21,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
21,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
21,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
22,1,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
23,1,Arthropod bite,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
23,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
23,3,Localised infection,Infections NEC,Infections - pathogen unspecified,Infec,N
23,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
24,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
24,2,Tic,Tic disorders,Changes in physical activity,Psych,N
25,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
25,2,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
25,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
25,4,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
25,5,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,6,Haemolytic uraemic syndrome,Anaemias haemolytic mechanical factor,Haemolyses and related conditions,Blood,N
25,7,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
25,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
25,9,Renal transplant,Renal therapeutic procedures,Renal and urinary tract therapeutic procedures,Surg,N
25,10,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
25,11,Type 2 diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
26,1,Renal cancer metastatic,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,Y
27,1,Headache,Headaches NEC,Headaches,Nerv,N
28,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
29,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
29,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
29,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
29,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
29,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
30,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
30,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
31,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
31,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,3,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
32,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
32,2,Headache,Headaches NEC,Headaches,Nerv,N
33,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
33,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
34,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
35,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
36,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
37,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
38,1,Migraine,Migraine headaches,Headaches,Nerv,N
39,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
39,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
39,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
39,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
39,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
40,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
40,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
40,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
40,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
40,5,Poor venous access,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
41,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
41,2,Migraine,Migraine headaches,Headaches,Nerv,N
41,3,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
42,1,Extravascular haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
43,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
43,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
43,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
44,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
45,1,Breakthrough haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
46,1,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
46,2,Quality of life decreased,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
47,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
47,2,Suspected COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
48,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
